ArticleCureus2025
Tumoral Melanosis: A Benign Mimicker of Malignant Disease.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report the case of a 60-year-old male with metastatic melanoma originating from a hyperpigmented lesion on the hard palate. During treatment with nivolumab, ipilimumab, cisplatin, and temozolomide, he developed multiple bluish macule-like lesions on the retroauricular region, neck, and anterior chest, surrounded by vitiligo-like halos. Given the clinical suspicion of in-transit metastases, biopsies were performed. Histopathological evaluation revealed dermal aggregates of melanin-laden macrophages, positive for CD68, in the absence of melanocytes, findings characteristic of tumoral melanosis. This case underscores the importance of biopsy for new pigmented lesions arising during melanoma immunotherapy. Recognizing tumoral melanosis is essential to avoid misinterpretation as disease progression and to guide appropriate clinical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.